M/s. MOODY Global Services - Pakistan DRAP Manufacturer Profile
Access the DRAP portfolio for M/s. MOODY Global Services via Pure Global AI. This manufacturer holds 20 registrations across 20 distinct products, with registrations ranging from 8/2/2023 to 8/24/2023 and spanning 4 risk classes.
This mirrors the Brazil holder experience with a concise snapshot and direct links to each DRAP registration.
Free Database
Powered by Pure Global AI
Pakistan DRAP
Manufacturer Snapshot
Overview of registrations for this manufacturer
20
Total Registrations
20
Distinct Products
8/24/2023
Latest Registration
8/2/2023
Earliest
Risk A
1
Risk C
4
Risk D
5
Risk B
1
Registrations (20)
Click a registration number to view details
Risk C
Pakistan
Lifotronic High-Sensitivity C Reactive Protein (e CLIA)
Pakistan
Lifotronic Cardiac Troponin (cTnI) Assay Kits (Lateral flow immunoassay)
Pakistan
Lifotronic Cytokeratin Fragments 19 (eCLIA)
Pakistan
Lifotronic D-dimer Assay Kits (Lateral flow immunoassay)
Pakistan
Lifotronic Heart Type Fatty Acid Binding Protein (Electrochemiluminesc ence Immunoassay)
Pakistan
Lifotronic Myoglobin (e CLIA)
Pakistan
Lifotronic Myoglobin Assay kits (Lateral flow immunoassay)
Pakistan
Lifotronic Myoglobin STAT (MYO STAT) e CLIA
Pakistan
Lifotronic N-terminal Pro-Brain Natriuretic Peptide (NT-proBNP) Assay Kits (Lateral Flow Immunoassay)
Pakistan
Lifotronic Pro-Gastrin Releasing Peptide (Electrochemiluminesc ence Immunoassay)
Risk D
Pakistan
Lifotronic SARS CoV-2 Neutralization Ab (e CLIA)
Risk D
Pakistan
Lifotronic SARS CoV-2 IgG Assay Kits (Lateral Flow Immunoassay)
Risk D
Pakistan
Lifotronic SARS CoV-2 IgM (e CLIA)
Risk D
Pakistan
Lifotronic SARS CoV-2 IgG (e CLIA)
Risk D
Pakistan
Lifotronic SARS CoV-2 Neutralization Ab (Lateral Flow Immunoassay)
Risk C
Pakistan
Lifotronic Squamous Cell Carcinoma (e CLIA)
Risk C
Pakistan
Lifotronic Troponin I (e CLIA)
Risk B
Pakistan
Lifotronic Testosterone(e CLIA)
Risk C
Pakistan
